SCHEMBL6863717

SCHEMBL6863717

CCCCCCCCCCC(CCCCCCCCCC)(C(=O)OCCCC)C(CCCCCCCCCC)(CCCCCCCCCC)C(=O)OCCCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.48
ALDH1A1 P00352 2/20 0.48
EPHX1 P07099 1/20 0.46
ATM Q13315 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
MEN1 O00255 1/20 0.45
MAPT P10636 1/20 0.45
KMT2A Q03164 1/20 0.45
TSHR P16473 6/20 0.44
LMNA P02545 1/20 0.44
DGKA P23743 1/20 0.44
TDP1 Q9NUW8 1/20 0.43
HPGD P15428 1/20 0.42
TP53 P04637 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAPK1 P28482 1/20 0.42
HCAR2 Q8TDS4 1/20 0.42
RAD52 P43351 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
CES2 O00748 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6753228 0.89 NAAA (0.47) NAAAALDH1A1EPHX1ATML3MBTL1
SCHEMBL5665790 0.87 NAAA (0.48) NAAAALDH1A1EPHX1ATML3MBTL1
SCHEMBL28340208 0.86 NAAA (0.50) NAAAALDH1A1EPHX1ATMTSHR
SCHEMBL6871664 0.86 MEN1 (0.59) NAAAATML3MBTL1MEN1MAPT
SCHEMBL27879368 0.85 NAAA (0.47) NAAAALDH1A1EPHX1ATML3MBTL1
SCHEMBL918326 0.83 NAAA (0.44) NAAAALDH1A1EPHX1ATML3MBTL1
SCHEMBL16167504 0.83 NAAA (0.44) NAAAALDH1A1EPHX1ATML3MBTL1
SCHEMBL10612416 0.83 NAAA (0.44) NAAAALDH1A1EPHX1ATML3MBTL1
SCHEMBL29025182 0.83 NAAA (0.44) NAAAALDH1A1EPHX1ATML3MBTL1
SCHEMBL20854005 0.82 NAAA (0.47) NAAAALDH1A1EPHX1ATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165633-B1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE SPA (IT) 2004-07-14 EP disclosed
US-6716939-B2 COMPRISING TITANIUM, MAGNESIUM, HALOGEN AND AN ELECTRON DONOR COMPOUND SELECTED FROM ESTERS OF SUBSTITUTED SUCCINIC ACIDS BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2004-04-06 US disclosed
US-20020183575-A1 Components and catalysts for the polymerization of olefins BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2002-12-05 US disclosed
EP-1165633-A1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS Basell Technology Company B.V. (NL) 2002-01-02 EP disclosed
WO-2001057099-A1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS BASELL TECHNOLOGY COMPANY B.V. (NL) 2001-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020183575-A1 Components and catalysts for the polymerization of olefins SCO2, ECI1, MT-CO2 NAAA 4712/4885ALDH1A1 3479/4885EPHX1 2160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.